Emerging Scientist Spotlight

Kyle Williams, PhD

Dr. Williams is using genome engineering technologies, such as CRISPR/Cas9, to identify new therapies that can be used for the treatment of tumors of patients with neurofibromatosis (NF1). In his research, Dr. Williams has found certain drugs that show selectivity towards killing NF1 tumor-related cells while leaving normal cells unharmed.

 
Kyle Williams U of M Researcher Jan 18th 2018.jpg